vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Floor & Decor Holdings, Inc. (FND). Click either name above to swap in a different company.

Floor & Decor Holdings, Inc. is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.2× Astrana Health, Inc.). Floor & Decor Holdings, Inc. runs the higher net margin — 3.5% vs 0.7%, a 2.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 2.0%). Floor & Decor Holdings, Inc. produced more free cash flow last quarter ($45.1M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 1.5%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Floor & Decor Holdings, Inc., branded as Floor & Decor, is a multi-channel American specialty retailer of hard surface flooring and related accessories that was founded in 2000 and headquartered in Smyrna, Georgia, United States.

ASTH vs FND — Head-to-Head

Bigger by revenue
FND
FND
1.2× larger
FND
$1.1B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+40.9% gap
ASTH
42.9%
2.0%
FND
Higher net margin
FND
FND
2.8% more per $
FND
3.5%
0.7%
ASTH
More free cash flow
FND
FND
$51.1M more FCF
FND
$45.1M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
1.5%
FND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
FND
FND
Revenue
$950.5M
$1.1B
Net Profit
$6.6M
$39.3M
Gross Margin
43.5%
Operating Margin
1.9%
4.6%
Net Margin
0.7%
3.5%
Revenue YoY
42.9%
2.0%
Net Profit YoY
184.4%
-17.2%
EPS (diluted)
$0.12
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
FND
FND
Q4 25
$950.5M
$1.1B
Q3 25
$956.0M
$1.2B
Q2 25
$654.8M
$1.2B
Q1 25
$620.4M
$1.2B
Q4 24
$665.2M
$1.1B
Q3 24
$478.7M
$1.1B
Q2 24
$486.3M
$1.1B
Q1 24
$404.4M
$1.1B
Net Profit
ASTH
ASTH
FND
FND
Q4 25
$6.6M
$39.3M
Q3 25
$373.0K
$57.3M
Q2 25
$9.4M
$63.2M
Q1 25
$6.7M
$48.9M
Q4 24
$-7.8M
$47.5M
Q3 24
$16.1M
$51.7M
Q2 24
$19.2M
$56.7M
Q1 24
$14.8M
$50.0M
Gross Margin
ASTH
ASTH
FND
FND
Q4 25
43.5%
Q3 25
43.4%
Q2 25
43.9%
Q1 25
43.8%
Q4 24
43.5%
Q3 24
43.5%
Q2 24
43.3%
Q1 24
42.8%
Operating Margin
ASTH
ASTH
FND
FND
Q4 25
1.9%
4.6%
Q3 25
2.0%
6.1%
Q2 25
3.1%
6.7%
Q1 25
3.3%
5.5%
Q4 24
0.1%
5.3%
Q3 24
5.9%
5.9%
Q2 24
6.2%
6.3%
Q1 24
7.5%
5.4%
Net Margin
ASTH
ASTH
FND
FND
Q4 25
0.7%
3.5%
Q3 25
0.0%
4.9%
Q2 25
1.4%
5.2%
Q1 25
1.1%
4.2%
Q4 24
-1.2%
4.3%
Q3 24
3.4%
4.6%
Q2 24
3.9%
5.0%
Q1 24
3.7%
4.6%
EPS (diluted)
ASTH
ASTH
FND
FND
Q4 25
$0.12
$0.36
Q3 25
$0.01
$0.53
Q2 25
$0.19
$0.58
Q1 25
$0.14
$0.45
Q4 24
$-0.14
$0.44
Q3 24
$0.33
$0.48
Q2 24
$0.40
$0.52
Q1 24
$0.31
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
FND
FND
Cash + ST InvestmentsLiquidity on hand
$429.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$2.4B
Total Assets
$2.2B
$5.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
FND
FND
Q4 25
$429.5M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
Stockholders' Equity
ASTH
ASTH
FND
FND
Q4 25
$779.3M
$2.4B
Q3 25
$775.5M
$2.4B
Q2 25
$765.5M
$2.3B
Q1 25
$745.4M
$2.2B
Q4 24
$712.7M
$2.2B
Q3 24
$704.6M
$2.1B
Q2 24
$678.9M
$2.0B
Q1 24
$653.5M
$2.0B
Total Assets
ASTH
ASTH
FND
FND
Q4 25
$2.2B
$5.5B
Q3 25
$2.2B
$5.5B
Q2 25
$1.4B
$5.4B
Q1 25
$1.3B
$5.4B
Q4 24
$1.4B
$5.1B
Q3 24
$1.3B
$4.9B
Q2 24
$1.3B
$4.8B
Q1 24
$1.2B
$4.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
FND
FND
Operating Cash FlowLast quarter
$-2.9M
$124.1M
Free Cash FlowOCF − Capex
$-6.0M
$45.1M
FCF MarginFCF / Revenue
-0.6%
4.0%
Capex IntensityCapex / Revenue
0.3%
7.0%
Cash ConversionOCF / Net Profit
-0.44×
3.15×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$64.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
FND
FND
Q4 25
$-2.9M
$124.1M
Q3 25
$10.0M
$102.5M
Q2 25
$90.9M
$84.1M
Q1 25
$16.6M
$71.2M
Q4 24
$-10.9M
$101.4M
Q3 24
$34.0M
$160.3M
Q2 24
$23.2M
$194.0M
Q1 24
$6.0M
$147.5M
Free Cash Flow
ASTH
ASTH
FND
FND
Q4 25
$-6.0M
$45.1M
Q3 25
$7.4M
$24.5M
Q2 25
$89.5M
$-10.0M
Q1 25
$13.6M
$4.4M
Q4 24
$-13.5M
$3.9M
Q3 24
$31.7M
$36.5M
Q2 24
$20.4M
$80.0M
Q1 24
$5.6M
$35.8M
FCF Margin
ASTH
ASTH
FND
FND
Q4 25
-0.6%
4.0%
Q3 25
0.8%
2.1%
Q2 25
13.7%
-0.8%
Q1 25
2.2%
0.4%
Q4 24
-2.0%
0.4%
Q3 24
6.6%
3.3%
Q2 24
4.2%
7.1%
Q1 24
1.4%
3.3%
Capex Intensity
ASTH
ASTH
FND
FND
Q4 25
0.3%
7.0%
Q3 25
0.3%
6.6%
Q2 25
0.2%
7.8%
Q1 25
0.5%
5.7%
Q4 24
0.4%
8.8%
Q3 24
0.5%
11.1%
Q2 24
0.6%
10.1%
Q1 24
0.1%
10.2%
Cash Conversion
ASTH
ASTH
FND
FND
Q4 25
-0.44×
3.15×
Q3 25
26.69×
1.79×
Q2 25
9.65×
1.33×
Q1 25
2.48×
1.46×
Q4 24
2.14×
Q3 24
2.11×
3.10×
Q2 24
1.21×
3.42×
Q1 24
0.40×
2.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

FND
FND

Laminate And Vinyl$310.1M27%
Tile$259.1M23%
Installation Materials And Tools$218.4M19%
Decorative Accessories And Wall Tile$177.0M16%
Wood$83.2M7%
Natural Stone$46.8M4%
Adjacent Categories$26.6M2%
Other$8.5M1%

Related Comparisons